Alzheimer's Drug Discovery Foundation (ADDF) — Cognitive Vitality Report
A review of the current evidence on molecular hydrogen and brain health — covering stroke recovery, traumatic brain injury, vascular dementia, and cognitive aging. What the research shows, and what it doesn't.
A 2023 review in Biomedicine & Pharmacotherapy examined hydrogen therapy across multiple mechanisms relevant to Alzheimer's disease — from amyloid reduction and neuroinflammation to mitochondrial support. Here is what the evidence currently shows.
